Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers-Reference-Cited by-同舟云学术

Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers

Published:2018-01-10 Issue:3 Volume:26 Page:382-386
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Grinshpun Albert,Halpern Naama,Granit Roy Zvi^ORCID,Hubert Ayala,Hamburger Tamar,Laitman Yael,Shacham-Shmueli Einat,Peerless Yehudit,Friedman Eitan,Peretz Tamar

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/s41431-017-0067-1.pdf

Reference25 articles.

1. Lord CJ, Ashworth A. BRCAness revisited. Nat Rev Cancer. 2016;16:110–20.

2. Kadouri L, Hubert A, Rotenberg Y, et al. Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations. J Med Genet. 2007;44:467–71.

3. Kirchhoff T, Satagopan JM, Kauff ND, et al. Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. J Natl Cancer Inst. 2004;96:68–70.

4. Niell BL, Rennert G, Bonner JD, Almog R, Tomsho LP, Gruber SB. BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst. 2004;96:15–21.

5. van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, et al. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet. 2005;42:711–9.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers;JCO Precision Oncology;2023-08

2. Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer;Cancers;2022-03-09

3. Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants;Frontiers in Oncology;2022-02-24

4. Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives;Frontiers in Oncology;2021-10-11

5. Low levels of BRCA1 protein expression predict a worse prognosis in stage I–II colon cancer;The International Journal of Biological Markers;2021-02-14